Lifeloc Technologies, Inc (LCTC): Revenue
$9.03M
Year ended 2025-12-31
$9.27M
Trailing 12 months to 2026-06-30
+2.1%
3-year compound annual growth
+7.3%
5-year compound annual growth
+0.2%
10-year compound annual growth
| Period ended | Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $9.03M | +5.7% | 2026-03-27, From 2025-01-01 |
| 2024-12-31 | $8.54M | -8.5% | 2026-03-27, From 2024-01-01 |
| 2023-12-31 | $9.33M | +10.0% | 2025-03-28, From 2023-01-01 |
| 2022-12-31 | $8.48M | +20.2% | 2024-04-01, From 2022-01-01 |
| 2021-12-31 | $7.05M | +11.0% | 2023-03-14, From 2021-01-01 |
| 2020-12-31 | $6.36M | -27.4% | 2022-03-03, From 2020-01-01 |
| 2019-12-31 | $8.75M | +3.7% | 2021-03-31, From 2019-01-01 |
| 2018-12-31 | $8.44M | +5.6% | 2020-03-24, From 2018-01-01 |
| 2017-12-31 | $7.99M | -4.7% | 2019-03-18, From 2017-01-01 |
| 2016-12-31 | $8.38M | -5.0% | 2018-03-26, From 2016-01-01 |
| 2015-12-31 | $8.83M | -5.5% | 2017-03-27, From 2015-01-01 |
| 2014-12-31 | $9.34M | +10.9% | 2016-03-22, From 2014-01-01 |
| 2013-12-31 | $8.43M | +23.2% | 2015-03-20, From 2013-01-01 |
| 2012-12-31 | $6.84M | -17.5% | 2014-03-18, From 2012-01-01 |
| 2011-12-31 | $8.29M | n/c | 2013-03-15, From 2011-01-01 |
| 2010-12-31 | $6.12M | n/a | 2012-03-16, From 2010-01-01 |
Revenue at similar companies
| Company | Year ended | Revenue | Change YoY |
|---|---|---|---|
| Lifeloc Technologies, Inc (LCTC) | 2025-12-31 | $9.03M | +5.7% |
| Scientific Industries Inc (SCND) | 2025-12-31 | $5.05M | +5.4% |
| Seer, Inc. (SEER) | 2025-12-31 | $16.58M | +17.0% |
| Precipio, Inc. (PRPO) | 2025-12-31 | $24.05M | +29.8% |
| Bionano Genomics, Inc. (BNGO) | 2025-12-31 | $28.51M | -7.4% |
| EyePoint, Inc. (EYPT) | 2025-12-31 | $31.37M | -27.5% |
| Rapid Micro Biosystems, Inc. (RPID) | 2025-12-31 | $33.59M | +19.7% |
| 908 Devices Inc. (MASS) | 2025-12-31 | $56.20M | +17.7% |
| Harvard Bioscience Inc (HBIO) | 2025-12-31 | $86.55M | -8.1% |
Compare LCTC, SCND, SEER, PRPO side by side · Screen every company in Laboratory Analytical Instruments ↗